BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 25936812)

  • 21. Topical atorvastatin 1% for prevention of skin toxicity in patients receiving radiation therapy for breast cancer: a randomized, double-blind, placebo-controlled trial.
    Ghasemi A; Ghashghai Z; Akbari J; Yazdani-Charati J; Salehifar E; Hosseinimehr SJ
    Eur J Clin Pharmacol; 2019 Feb; 75(2):171-178. PubMed ID: 30291370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using the Skindex-16 and Common Terminology Criteria for Adverse Events to assess rash symptoms: results of a pooled-analysis (N0993).
    Atherton PJ; Burger KN; Loprinzi CL; Neben Wittich MA; Miller RC; Jatoi A; Sloan JA
    Support Care Cancer; 2012 Aug; 20(8):1729-35. PubMed ID: 21922203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Boron-Based Gel on Radiation-Induced Dermatitis in Breast Cancer: A Double-Blind, Placebo-Controlled Trial.
    Aysan E; Idiz UO; Elmas L; Saglam EK; Akgun Z; Yucel SB
    J Invest Surg; 2017 Jun; 30(3):187-192. PubMed ID: 27700210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical silymarin administration for prevention of acute radiodermatitis in breast cancer patients: A randomized, double-blind, placebo-controlled clinical trial.
    Karbasforooshan H; Hosseini S; Elyasi S; Fani Pakdel A; Karimi G
    Phytother Res; 2019 Feb; 33(2):379-386. PubMed ID: 30479044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nigella sativa L. for prevention of acute radiation dermatitis in breast cancer: A randomized, double-blind, placebo-controlled, clinical trial.
    Rafati M; Ghasemi A; Saeedi M; Habibi E; Salehifar E; Mosazadeh M; Maham M
    Complement Ther Med; 2019 Dec; 47():102205. PubMed ID: 31780017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind, vehicle-controlled clinical study to evaluate the efficacy of MAS065D (XClair), a hyaluronic acid-based formulation, in the management of radiation-induced dermatitis.
    Primavera G; Carrera M; Berardesca E; Pinnaró P; Messina M; Arcangeli G
    Cutan Ocul Toxicol; 2006; 25(3):165-71. PubMed ID: 16980242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Three-Arm Randomized Phase III Trial: Quality Aloe and Placebo Cream Versus Powder as Skin Treatment During Breast Cancer Radiation Therapy.
    Hoopfer D; Holloway C; Gabos Z; Alidrisi M; Chafe S; Krause B; Lees A; Mehta N; Tankel K; Strickland F; Hanson J; King C; Ghosh S; Severin D
    Clin Breast Cancer; 2015 Jun; 15(3):181-90.e1-4. PubMed ID: 25619686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double-blind, randomised, vehicle-controlled clinical study to evaluate the efficacy of MAS065D in limiting the effects of radiation on the skin: interim analysis.
    Leonardi MC; Gariboldi S; Ivaldi GB; Ferrari A; Serafini F; Didier F; Mariani L; Castiglioni S; Orecchia R
    Eur J Dermatol; 2008; 18(3):317-21. PubMed ID: 18474463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the effect of topical agents on radiation-induced skin disease by reflectance spectrophotometry.
    Rizza L; D'Agostino A; Girlando A; Puglia C
    J Pharm Pharmacol; 2010 Jun; 62(6):779-85. PubMed ID: 20636866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intensity modulated radiation therapy (IMRT) decreases acute skin toxicity for women receiving radiation for breast cancer.
    Freedman GM; Anderson PR; Li J; Eisenberg DF; Hanlon AL; Wang L; Nicolaou N
    Am J Clin Oncol; 2006 Feb; 29(1):66-70. PubMed ID: 16462506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of laser therapy on quality of life in patients with radiation-induced breast telangiectasias.
    Rossi AM; Blank NR; Nehal K; Dusza S; Lee EH
    Lasers Surg Med; 2018 Apr; 50(4):284-290. PubMed ID: 29266570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal trends in skin-related and global quality of life among women with breast radiodermatitis: A pilot study.
    Beamer LC; Grant M
    Eur J Oncol Nurs; 2018 Apr; 33():22-27. PubMed ID: 29551173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of an essential oil mixture on skin reactions in women undergoing radiotherapy for breast cancer: a pilot study.
    Halm MA; Baker C; Harshe V
    J Holist Nurs; 2014 Dec; 32(4):290-303. PubMed ID: 24668063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective randomized, placebo-controlled skin care study in women diagnosed with breast cancer undergoing radiation therapy.
    Gosselin TK; Schneider SM; Plambeck MA; Rowe K
    Oncol Nurs Forum; 2010 Sep; 37(5):619-26. PubMed ID: 20797953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial.
    Stainer R; Matthews S; Arshad SH; McDonald S; Robinson J; Schapira C; Foote KD; Baird-Snell M; Gregory T; Pollock I; Stevens MT; Edwards AM
    Br J Dermatol; 2005 Feb; 152(2):334-41. PubMed ID: 15727648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective Study of Breast Radiation Dermatitis.
    Drost L; Li N; Vesprini D; Sangha A; Lee J; Leung E; Rakovitch E; Yee C; Chow E; Ruschin M
    Clin Breast Cancer; 2018 Oct; 18(5):e789-e795. PubMed ID: 29622382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized, double-blind trial on the use of 1% hydrocortisone cream for the prevention of acute radiation dermatitis.
    Meghrajani CF; Co HS; Arcillas JG; Maaño CC; Cupino NA
    Expert Rev Clin Pharmacol; 2016; 9(3):483-91. PubMed ID: 26619355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal Topical Agent for Radiation Dermatitis During Breast Radiotherapy: A Pilot Study.
    Fenton-Kerimian M; Cartwright F; Peat E; Florentino R; Maisonet O; Budin W; Rolnitzky L; Formenti S
    Clin J Oncol Nurs; 2015 Aug; 19(4):451-5. PubMed ID: 26207710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylaxis of radiation dermatitis with a topical cortisone cream.
    Potera ME; Lookingbill DP; Stryker JA
    Radiology; 1982 Jun; 143(3):775-7. PubMed ID: 7079509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase I study of topical epigallocatechin-3-gallate (EGCG) in patients with breast cancer receiving adjuvant radiotherapy.
    Zhao H; Zhu W; Jia L; Sun X; Chen G; Zhao X; Li X; Meng X; Kong L; Xing L; Yu J
    Br J Radiol; 2016; 89(1058):20150665. PubMed ID: 26607642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.